Modern Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41M Buy
9,910
+766
+8% +$116K 0.01% 468
2026
Q2
$1.43M Sell
9,144
-234
-2% -$35.1K 0.02% 440
2026
Q1
$1.45M Sell
9,378
-663
-7% -$102K 0.02% 349
2025
Q4
$1.38M Buy
10,041
+163
+2% +$21.3K 0.03% 353
2025
Q3
$1.27M Buy
9,878
+342
+4% +$41.7K 0.03% 343
2025
Q2
$1.15M Buy
9,536
+1,781
+23% +$201K 0.03% 345
2025
Q1
$864K Buy
+7,755
New +$826K 0.03% 323
2024
Q4
– Sell
-1,791
Closed -$206K – 596
2024
Q3
$206K Buy
+1,791
New +$203K 0.01% 414

Other funds holding NVS

Modern Wealth Management's NVS Position: Q3 2026 in Review

Modern Wealth Management increased its Novartis (NVS) stake by 8.4% in Q3 2026, buying an estimated $116K and bringing the position to 9,910 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #468.

Modern Wealth Management first reported a position in NVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.45M in Q1 2026. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Modern Wealth Management held 9,910 shares of Novartis worth $1.41M as of Q3 2026.
  • Modern Wealth Management bought 766 Novartis shares in Q3 2026, an estimated $116K.
  • Novartis made up 0.01% of Modern Wealth Management's portfolio in Q3 2026, its #468 holding.
  • Modern Wealth Management first reported a position in Novartis in Q3 2024 and has held it in 8 quarters since.
  • Modern Wealth Management's Novartis position peaked at $1.45M in Q1 2026.
  • 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Modern Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.